A new clinic for a new problem
A hospital in Liverpool has opened a new clinic. It is the first of its kind in the United Kingdom. Its purpose is to treat children and teenagers suffering from severe bladder damage caused by the use of ketamine. The facility is at Alder Hey, one of the country's best known children's hospitals, and its creation is a direct response by medics to a problem they are seeing with increasing frequency in their wards. This is a new problem. It requires a new solution. Referrals include children as young as thirteen.
The condition has a name. Ketamine-induced uropathy. It is described by doctors as severe and painful. For some, it is devastating. The damage results from what sources call sustained use of the drug, which can lead to addiction. The clinic at Alder Hey is the first specialist unit established specifically for people under eighteen who are experiencing these chronic bladder issues. Before its existence, these young patients would have been seen in general urology departments, their cases part of a much wider and less specific caseload. Now they have a dedicated service.
The decision to open a dedicated unit signifies a change. It points to a specific, identifiable group of patients whose needs are complex enough to require their own specialised medical pathway. The hospital has not released figures on patient numbers. It has confirmed a surge. That surge prompted action. The creation of a physical clinic in Liverpool provides a concrete location for a problem that was, until recently, a collection of disparate and tragic individual cases appearing across the National Health Service.
The consequences for these young people can be permanent. They are life altering. In the most severe cases of ketamine-induced uropathy, the damage to the urinary system is so extensive that patients require dialysis to stay alive. This is a procedure usually associated with kidney failure in older adults, not with bladder problems in teenagers. The fact that medics at Alder Hey are treating children who face such outcomes is the central reason the clinic was established. It is a place for the worst cases. It is a place for children whose drug use has led them to the brink of organ failure before they have even finished school.
The drug's path to the playground
Ketamine has a legitimate purpose. It is a medicine. Doctors use it as an anaesthetic for humans and for animals, a function it has performed for more than half a century. It was first synthesised in 1962. It offered a crucial advantage over previous anaesthetics by being less likely to dangerously slow a patient’s breathing. This property made it useful. Today it remains a vital tool in accident and emergency departments, in operating theatres and on battlefields. Its effects are predictable and powerful. They are also the reason for its second, non medical use. The drug has another life. It is an illicit substance.
This recreational use is not a recent phenomenon. For decades, ketamine, known by street names like 'K' or 'Special K', has been a feature of the UK’s nightlife and music festival scenes. Users seek the dissociative state it creates, a feeling of separation from one’s own body and surroundings. The experience can range from a mild sense of detachment to a near total sensory disconnection sometimes called a 'K-hole'. This is the effect that has driven its demand as a party drug. What appears to be shifting is not the drug’s properties, but the profile of its user. The patients at the Alder Hey clinic are not clubbers in their twenties. They are children.
In the United Kingdom, ketamine is a controlled substance. The government classifies it as a Class B drug. This places it in the same legal category as cannabis, speed and codeine. It was upgraded to Class B from Class C in 2014, a move that increased the legal penalties for its misuse following advice about its long term harms, including bladder damage. The maximum penalty for possessing ketamine is now five years in prison. For producing it or supplying it to others, the sentence can be up to fourteen years. Despite these legal sanctions, the drug is widely available. It is sold illegally as a grainy white powder for snorting. It is sold as a liquid. The existence of the Liverpool clinic shows that this availability now reaches into schools and into playgrounds, with teenagers engaging in what medics call the sustained use required to cause devastating physical injury. The drug’s journey from the operating table to the adolescent bladder is a story of diversion and proliferation.
How ketamine destroys the bladder
The harm is physical. It is not psychological. Ketamine’s journey through the body leaves a trail of chemical damage, and the final collection point for this damage is the bladder. When a person takes ketamine, their liver metabolises the drug into other compounds, which are then concentrated in the urine to be flushed out of the system. These byproducts are directly toxic to the delicate cells that form the bladder's protective inner lining. This sensitive layer, called the urothelium, is not equipped to handle a sustained chemical assault, and with repeated exposure to high concentrations of these metabolites, it begins to break down. The initial result is severe inflammation. Ulcers form. The body’s own waste product becomes a corrosive agent.
This internal damage manifests as a severe and painful condition. It is called ketamine-induced uropathy. For the user, the first sign is often pain and a desperate, constant urge to urinate, sometimes dozens of times an hour, even when the bladder is empty. As the bladder lining becomes progressively more scarred and ulcerated, the organ itself begins to change. The walls thicken. They harden with fibrotic tissue. This means the bladder can no longer stretch to hold a normal volume of urine, shrinking its effective capacity from around 500 millilitres to a fraction of that size. The result is chronic pain, debilitating frequency and incontinence. The user loses control. They become entirely dependent on proximity to a toilet.
In the most severe cases, the damage is irreversible. There is no cure. As the bladder fails completely, urine can back up into the kidneys, a condition which can lead to renal failure and death if left untreated. At this stage, medics are no longer trying to heal the organ. They are trying to save the patient’s life. The surgical options are extreme and life altering, particularly for a teenager who is still growing. The most common procedure is a full cystectomy, the complete removal of the diseased bladder, after which urine must be diverted out of the body through an opening in the abdomen and collected in an external urostomy bag. This bag must be worn for life. For patients whose kidneys have already failed, the only alternative is lifelong dialysis. It is a devastating outcome. These are the choices facing children at Alder Hey.
Counting the cases is difficult
How many teenagers need this surgery? The answer is unknown. Nobody is counting. The new specialist unit at Alder Hey in Liverpool is, for now, the only official data point for the problem in the United Kingdom. It is a local response to a local crisis. There is no national register for ketamine-induced uropathy in people under eighteen, meaning there is no central mechanism for collating the number of children affected, tracking the geographical spread of cases or monitoring whether the problem is getting worse. The clinic’s opening is evidence of a need perceived by doctors on the ground, but the true scale of that need remains entirely unquantified by national health bodies. It is a statistical black hole.
The data is not being hidden. It is simply not being collected in a usable form. A child presenting with severe bladder damage might be seen by a paediatrician, a urologist, or a child and adolescent mental health service. Each case might be logged within an individual NHS trust’s internal system under a general code for bladder dysfunction or pelvic pain, with the link to ketamine recorded only in unstructured clinical notes. Without a specific, mandatory reporting requirement for ketamine-induced bladder damage in minors, these individual incidents remain isolated. They are fragments. They do not form a coherent national picture, preventing public health officials from accurately assessing the condition's prevalence and dedicating resources accordingly. A GP in Leeds and a hospital consultant in Brighton could be treating teenagers with identical, drug-induced injuries without any system connecting those two facts.
The patient’s own journey also obscures the true numbers. Teenagers, particularly those as young as thirteen, are often reluctant to disclose illicit drug use to doctors or parents. This complicates diagnosis. The initial symptoms of pain and frequent urination can easily be mistaken for a standard urinary tract infection, for which a GP would prescribe antibiotics. It is only when the condition fails to respond to standard treatment, and the pain becomes unbearable, that more detailed investigation might begin and the link to ketamine might be revealed. This delay means a single case could generate multiple appointments and incorrect diagnoses before being properly identified, further muddying any attempt to count the real number of individuals affected from the outset. The data trail is confused. It is unreliable. The numbers that do exist are likely a significant underestimate of the problem.
Official policy has yet to form
The new clinic is a local solution. It is a Merseyside initiative. The decision to open a specialist service at Alder Hey Children’s Hospital was made by clinicians on the ground, responding to a new and distressing pattern of injury they were seeing in their own wards. There is no equivalent national programme from NHS England. No central directive has ordered the creation of such clinics, and no specific service specification exists for trusts to follow if they wish to establish one. The national body has not issued any formal guidance on treating ketamine-induced uropathy in adolescents. This means the expertise developing in Liverpool is, for now, isolated there. A child in Cornwall or Cumbria with the same condition does not have a designated, nationally recognised treatment pathway to follow. The response is fragmented. It is entirely reactive.
Responsibility for drug policy is not simple. It is split. The Home Office classifies ketamine as a Class B substance under the Misuse of Drugs Act 1971, a legal status that focuses on policing and criminal sanctions for possession and supply. This framework has not prevented the drug’s use by teenagers. The department’s public messaging on illegal drugs tends to focus on criminality and general health risks, rather than the specific, catastrophic organ damage now being treated in children as young as thirteen. There is no high profile Home Office campaign warning young people that using ketamine could lead to them needing a catheter or having their bladder removed before they are old enough to vote. The legal classification exists. The specific health warning does not.
Schools are silent. The Department for Education is responsible for curriculum content, including the health education that is meant to inform pupils about the dangers of substance misuse. The current framework for schools offers broad advice on teaching about drugs, alcohol and lifestyle choices. It does not contain specific modules on the emerging threat of ketamine, nor does it provide teachers with government approved resources detailing the symptoms and consequences of ketamine bladder. The information is not in the lesson plan. A teacher in a London comprehensive and a youth worker in a Manchester club have no official material to show a teenager what this drug does. The government has not provided it. Policy has not caught up with the reality facing doctors at Alder Hey.
More specialist clinics are likely
Alder Hey is the benchmark. Its existence poses a direct question to every other NHS trust. Doctors and hospital managers outside Liverpool will now monitor their own admissions data for similar patterns of bladder damage in young people, looking for the same clinical signs that Merseyside medics identified. They have a precedent. The Liverpool clinic provides a blueprint. It is a model to be copied or ignored.
The indicators are specific. Paediatric specialists will be alert to any rise in referrals for conditions like intractable cystitis, unexplained pelvic pain and incontinence among teenagers. These are the clinical markers. A single case is an anomaly. A cluster of cases presenting in one city, perhaps Birmingham or Sheffield, would suggest a localised problem that directly mirrors the situation which forced clinicians in Liverpool to act. Public health officials need that data. They need it to understand the scale of the damage being done to children across the country, not just in one hospital in the north west of England.
The decision to fund more clinics will not be made in isolation. It will be driven by what happens in GP surgeries and hospital emergency departments long before a child is ever seen by a urology consultant. The information from Alder Hey changes things. It gives every general practitioner a new and serious diagnostic possibility to consider when a young person describes severe urinary distress. The symptoms are devastating. Before now, a doctor might have investigated such problems in a thirteen year old as a rare congenital issue or a stubborn infection. Now, ketamine is a possibility. This alters the questions a doctor might ask and it changes the tests they will almost certainly order.
Liverpool’s clinic could remain a unique outlier. That is one possible future. It might be a response to a uniquely concentrated problem on Merseyside, a tragic but contained phenomenon that does not repeat itself elsewhere in the United Kingdom. The alternative is that it becomes a template. If heavy ketamine use among teenagers continues or grows, then other major children’s hospitals will inevitably face the exact same clinical demand for bladder reconstruction and dialysis. The need could be immense. The Royal Manchester Children's Hospital and London’s Great Ormond Street will be watching the referral numbers from Liverpool while simultaneously monitoring their own emergency admissions for the same symptoms. The answer to whether more clinics are needed rests inside that data, and on whether the doctors at Alder Hey are pioneers treating a new wave of patients, or specialists handling a tragic but local anomaly.
Sources. Guardian UK: Children as young as 13 being referred to UK hospital suffering from ‘ketamine bladder’. Evening Standard: Children as young as 13 referred to specialist clinic for ‘ketamine bladder’.
Analysis. Drafted with AI assistance from the sources listed above and reviewed by an editor before publication. Jnews links to the organisations it writes about.
